146 related articles for article (PubMed ID: 28656291)
1. USP7 is associated with greater disease activity in systemic lupus erythematosus via stabilization of the IFNα receptor.
Yu Y; Su Z; Wang Z; Xu H
Mol Med Rep; 2017 Aug; 16(2):2274-2280. PubMed ID: 28656291
[TBL] [Abstract][Full Text] [Related]
2. Identification of Cyclin-Dependent Kinase 1 as a Novel Regulator of Type I Interferon Signaling in Systemic Lupus Erythematosus.
Wu L; Qin Y; Xia S; Dai M; Han X; Wu Y; Zhang X; Ma J; Wang Y; Tang Y; Liu Z; Zhu W; Jallal B; Yao Y; Qu B; Shen N
Arthritis Rheumatol; 2016 May; 68(5):1222-32. PubMed ID: 26663909
[TBL] [Abstract][Full Text] [Related]
3. USP7-TRIM27 axis negatively modulates antiviral type I IFN signaling.
Cai J; Chen HY; Peng SJ; Meng JL; Wang Y; Zhou Y; Qian XP; Sun XY; Pang XW; Zhang Y; Zhang J
FASEB J; 2018 Oct; 32(10):5238-5249. PubMed ID: 29688809
[TBL] [Abstract][Full Text] [Related]
4. Identification and Characterization of USP7 Targets in Cancer Cells.
Georges A; Marcon E; Greenblatt J; Frappier L
Sci Rep; 2018 Oct; 8(1):15833. PubMed ID: 30367141
[TBL] [Abstract][Full Text] [Related]
5. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
6. Activation of JAK-STAT1 signal transduction pathway in lesional skin and monocytes from patients with systemic lupus erythematosus.
Li J; Zhao S; Yi M; Hu X; Li J; Xie H; Zhu W; Chen M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):109-15. PubMed ID: 21368418
[TBL] [Abstract][Full Text] [Related]
7. A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.
Zhang Q; Cao C; Gong W; Bao K; Wang Q; Wang Y; Bi L; Ma S; Zhao J; Liu L; Tian S; Zhang K; Yang J; Yao Z; Song N; Shi L
Theranostics; 2020; 10(23):10769-10790. PubMed ID: 32929379
[No Abstract] [Full Text] [Related]
8. Constitutive phosphorylation of interferon receptor A-associated signaling proteins in systemic lupus erythematosus.
Ramírez-Vélez G; Medina F; Ramírez-Montaño L; Zarazúa-Lozada A; Hernández R; Llorente L; Moreno J
PLoS One; 2012; 7(7):e41414. PubMed ID: 22859983
[TBL] [Abstract][Full Text] [Related]
9. The deubiquitinase USP7 stabilizes Maf proteins to promote myeloma cell survival.
He Y; Wang S; Tong J; Jiang S; Yang Y; Zhang Z; Xu Y; Zeng Y; Cao B; Moran MF; Mao X
J Biol Chem; 2020 Feb; 295(7):2084-2096. PubMed ID: 31822558
[TBL] [Abstract][Full Text] [Related]
10. Luteolin sensitizes the antiproliferative effect of interferon α/β by activation of Janus kinase/signal transducer and activator of transcription pathway signaling through protein kinase A-mediated inhibition of protein tyrosine phosphatase SHP-2 in cancer cells.
Tai Z; Lin Y; He Y; Huang J; Guo J; Yang L; Zhang G; Wang F
Cell Signal; 2014 Mar; 26(3):619-28. PubMed ID: 24333668
[TBL] [Abstract][Full Text] [Related]
11. Small-molecule inhibitors of ubiquitin-specific protease 7 enhance type-I interferon antiviral efficacy by destabilizing SOCS1.
Yuan Y; Miao Y; Zeng C; Liu J; Chen X; Qian L; Wang X; Qian F; Yu Z; Wang J; Qian G; Fu Q; Lv H; Zheng H
Immunology; 2020 Mar; 159(3):309-321. PubMed ID: 31691271
[TBL] [Abstract][Full Text] [Related]
12. USP7 promotes cell proliferation through the stabilization of Ki-67 protein in non-small cell lung cancer cells.
Zhang C; Lu J; Zhang QW; Zhao W; Guo JH; Liu SL; Wu YL; Jiang B; Gao FH
Int J Biochem Cell Biol; 2016 Oct; 79():209-221. PubMed ID: 27590858
[TBL] [Abstract][Full Text] [Related]
13. PTPN22 Variant R620W Is Associated With Reduced Toll-like Receptor 7-Induced Type I Interferon in Systemic Lupus Erythematosus.
Wang Y; Ewart D; Crabtree JN; Yamamoto A; Baechler EC; Fazeli P; Peterson EJ
Arthritis Rheumatol; 2015 Sep; 67(9):2403-14. PubMed ID: 26018863
[TBL] [Abstract][Full Text] [Related]
14. Deubiquitylation and stabilization of ARMC5 by ubiquitin-specific processing protease 7 (USP7) are critical for RCC proliferation.
Yan G; Liu N; Tian J; Fu Y; Wei W; Zou J; Li S; Wang Q; Li K; Wang J
J Cell Mol Med; 2021 Mar; 25(6):3149-3159. PubMed ID: 33544460
[TBL] [Abstract][Full Text] [Related]
15. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits.
Mitxitorena I; Somma D; Mitchell JP; Lepistö M; Tyrchan C; Smith EL; Kiely PA; Walden H; Keeshan K; Carmody RJ
J Biol Chem; 2020 Aug; 295(33):11754-11763. PubMed ID: 32587091
[TBL] [Abstract][Full Text] [Related]
16. The occurrence of lupus nephritis is regulated by USP7-mediated JMJD3 stabilization.
Zhang F; Zhang B; Tang R; Jiang H; Ji Z; Chen Y; Feng H
Immunol Lett; 2021 Jul; 235():41-50. PubMed ID: 33895173
[TBL] [Abstract][Full Text] [Related]
17. Anti-interferon alpha treatment in SLE.
Kirou KA; Gkrouzman E
Clin Immunol; 2013 Sep; 148(3):303-12. PubMed ID: 23566912
[TBL] [Abstract][Full Text] [Related]
18. Protein phosphatase 2A regulated by USP7 is polyubiquitinated and polyneddylated.
Do HA; Baek KH
Oncol Rep; 2022 Jul; 48(1):. PubMed ID: 35593311
[TBL] [Abstract][Full Text] [Related]
19. Targeting ubiquitin specific protease 7 in cancer: A deubiquitinase with great prospects.
Yeasmin Khusbu F; Chen FZ; Chen HC
Cell Biochem Funct; 2018 Jul; 36(5):244-254. PubMed ID: 29781103
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Inflammasome Activity in Systemic Lupus Erythematosus Is Mediated via Type I Interferon-Induced Up-Regulation of Interferon Regulatory Factor 1.
Liu J; Berthier CC; Kahlenberg JM
Arthritis Rheumatol; 2017 Sep; 69(9):1840-1849. PubMed ID: 28564495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
